$0.091
-0.061 (-67.02%)Zum Schluss
- Hoch
- 0.157
- Eröffnung
- 0.137
- Volumengewichteter Durchschnittskurs
- 0.11
- Volumen
- 70.12M
- Marktkap.
- —
- Tief
- 0.091
- Umsatz
- 7.90M
- EV/EBITDA, TTM
- -8.03
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
KI-Analyse of Synergy CHC Corp (SNYR)
VerkaufenSynergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.
Bewertungskennzahlen
Event-Zeitleiste
News
9.505-15seekingalphaSynergy CHC Reports Q1 Loss with Revenue Decline
9.504-02seekingalphaSynergy CHC Reports FY 2025 Earnings Results
9.504-01Yahoo FinanceSynergy CHC Corp Reports Significant Q4 Losses Amid Revenue Decline
9.503-30NewsfilterSynergy CHC Corp. Updates Q4 and Full Year 2025 Financial Results Release Date
1.002-21Yahoo FinanceNew Show to Air Tonight on Bloomberg Television
SNYR FAQ – beantwortet von Alphio AI
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications. It operates in the Healthcare sector.
Synergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenÄhnliche Artikel
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.